ABL1 and myeloproliferative neoplasm: To address the question of whether there are risk factors for the development of secondary BCR::ABL1-negative MPN or CML, we examined the gender and age distribution of the patients at the time of primarily diagnosed BCR::ABL1-negative MPN or CML.